- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement Nos.333-159247,333-176305,333-176306,333-198070, , and333-225890 on FormS-8, and Registration Statement Nos.333-150898,333-172849,333-194747,333-208674,333-213138,333-218112,333-226402,333-230085, and333-233193 on FormS-3 of our reports dated March 16, 2020 with respect to the consolidated financial statements of Galectin Therapeutics, Inc. and subsidiaries (the “Company”) and the effectiveness of internal control over financial reporting of the Company included in this Annual Report on Form10-K of the Company for the year ended December 31, 2019.
/S/ CHERRY BEKAERT LLP
Atlanta, Georgia
March 16, 2020